Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation

被引:27
|
作者
Wingate, Jonathan T. [1 ]
Brandenberger, Jared [2 ]
Weiss, Andrew [3 ]
Scovel, Lauren G. [2 ]
Kuhr, Christian S. [2 ]
机构
[1] Madigan Army Med Ctr, Dept Urol, Tacoma, WA 98431 USA
[2] Virginia Mason Med Ctr, Dept Urol & Renal Transplantat, Seattle, WA 98101 USA
[3] Virginia Mason Med Ctr, Dept Nephrol & Renal Transplantat, Seattle, WA 98101 USA
关键词
bacteriuria; BK nephropathy; BK viremia; ureteral stent; URINARY-TRACT-INFECTION; SINGLE-CENTER EXPERIENCE; UROLOGICAL COMPLICATIONS; RENAL-TRANSPLANTATION; NEPHROPATHY; IMPACT; RECIPIENTS; VIRUS;
D O I
10.1111/tid.12644
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesUreteral stents are used in kidney transplantation (KTX) to decrease post-operative complications, but they are associated with BK polyomavirus viremia (BKV). Our primary outcome was to determine the association between ureteral stent duration and BKV. Secondary outcome measures were the association between bacteriuria and stent duration or use of ureteral stent strings. MethodsBetween January 2010 and January 2015, 403 patients underwent KTX at the Virginia Mason Medical Center and met inclusion criteria. Stent duration was classified as short (<3weeks) or long (>3weeks). Multivariate logistic regression models were created to assess for factors associated with BKV. The covariates in the BKV model were chosen a priori based on stent duration and risk factors previously described in the literature. ResultsUreteral stents were placed in 304 (75.4%) transplants. Stent strings were left attached in 166 (54.6%) patients. On multivariate analyses, long stent duration was significantly associated with increased risk of BKV compared with no stent (odds ratio [OR] 1.92, P=.044, 95% confidence interval [CI] 1.04-3.74). Short stent duration was not associated with BKV. Sixty-two (15.4%) patients had bacteriuria. Bacteriuria was associated with female gender (OR 2.77, P<.001, 95% CI 1.58-4.95), and there was a dose-dependent effect with stent duration compared with no stentshort duration (OR 2.46, P=.049, 95% CI 1.05-6.49) and long duration (OR 3.58, P=.004, 95% CI 1.58-9.25). Stent strings were not associated with either complication. ConclusionsThe association between ureteral stents and BKV may be dose dependent.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney Transplantation
    Hashim, Faris
    Rehman, Shehzad
    Gregg, Jon A.
    Dharnidharka, Vikas R.
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [2] URETERAL STENT PLACEMENT INCREASES THE RISK FOR DEVELOPING BK VIRURIA AND VIREMIA AFTER KIDNEY TRANSPLANTATION
    Hashim, Faris
    Rehman, Shehzad
    Dharnidharka, Vikas
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : A45 - A45
  • [3] Ureteral Stent Placement Increases the Risk of BK Viremia in the First Year After Kidney Transplantation: A Validation Study
    Maliakkal, J.
    Chen, H.
    Fong, D.
    Agarwal, N.
    Zheng, J.
    Horwedel, T.
    Brennan, D.
    Dharnidharka, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 553 - 553
  • [4] Ureteral Stent Placement Increases the Risk of BK Viremia in the First Year After Kidney Transplantation: A Validation Study.
    Maliakkal, J.
    Chen, H.
    Fong, D.
    Agarwal, N.
    Zheng, J.
    Horwedel, T.
    Brennan, D.
    Dharnidharka, V.
    TRANSPLANTATION, 2014, 98 : 553 - 553
  • [5] HLA-B51 Reduces Risk of BK Polyomavirus Viremia After Kidney Transplantation
    Wunderink, Herman. F.
    Haasnoot, Geert W.
    de Brouwer, Caroline S.
    van Zwet, Erik W.
    Kroes, Aloysius C. M.
    de Fijter, Johan W.
    Rotmans, Joris I.
    Claas, Frans H. J.
    Feltkamp, Mariet C. W.
    TRANSPLANTATION, 2019, 103 (11) : E386 - E387
  • [6] Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation
    Maliakkal, Joseph G.
    Brennan, Daniel C.
    Goss, Charles
    Horwedel, Timothy A.
    Chen, Howard
    Fong, Dennis K.
    Agarwal, Nikhil
    Zheng, Jie
    Schechtman, Kenneth B.
    Dharnidharka, Vikas R.
    TRANSPLANT INTERNATIONAL, 2017, 30 (02) : 153 - 161
  • [7] Ureteral stent placement and BK viremia in kidney transplant recipients
    Kayler, L.
    Zendejas, I.
    Schain, D.
    Magliocca, J.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (02) : 202 - 207
  • [8] Ureteral Stent Placement and BK Viremia in Kidney Transplant Recipients
    Kulkarni, Rupak
    Zendejas, Ivan
    Schain, Denise
    Magliocca, Joseph
    Kayler, Liise
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 74 - 75
  • [9] Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation
    Molnar, Miklos Z.
    Potluri, Vishnu S.
    Schaubel, Douglas E.
    Sise, Meghan E.
    Concepcion, Beatrice P.
    Forbes, Rachel C.
    Blumberg, Emily
    Bloom, Roy D.
    Shaffer, David
    Chung, Raymond T.
    Strohbehn, Ian A.
    Elias, Nahel
    Azhar, Ambreen
    Shah, Mital
    Sawinski, Deirdre
    Binari, Laura A.
    Talwar, Manish
    Balaraman, Vasanthi
    Bhalla, Anshul
    Eason, James D.
    Besharatian, Behdad
    Trofe-Clark, Jennifer
    Goldberg, David S.
    Reese, Peter P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (02) : 599 - 609
  • [10] Association of Donor Hepatitis C Virus Infection Status and Risk of Bk Polyomavirus Viremia After Kidney Transplantation
    Potluri, V. S.
    Schaubel, D. E.
    Sise, M. E.
    Concepcion, B. P.
    Forbes, R. C.
    Blumberg, E. A.
    Goldberg, D.
    Reese, P. P.
    Bloom, R.
    Shaffer, D.
    Chung, R.
    Sawinski, D.
    Strohben, I.
    Elias, N.
    Azhar, A.
    Shah, M.
    Eason, J.
    Binari, L. A.
    Talwar, M.
    Balaraman, V.
    Bhalla, A.
    Besharatian, B.
    Molnar, M. Z.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 482 - 482